Hyperlipidemia

Related records

Broader conditions (4)

• Disease
• Disease by developmental or physiological process
• Human disease
• Metabolic disease

Narrower conditions (19)

• Cholesterol-ester transfer protein deficiency
• Familial apolipoprotein C-II deficiency
• Familial hypercholesterolemia
• Familial hyperlipidemia
• Familial lipoprotein lipase deficiency
• Homozygous familial hypercholesterolemia
• Hyperalphalipoproteinemia
• Hypercholesterolemia due to cholesterol 7alpha-hydroxylase deficiency
• Hypercholesterolemia, autosomal dominant, 3
• Hypercholesterolemia, autosomal dominant, type B
• Hypercholesterolemia, familial, 1
• Hypercholesterolemia, familial, 4
• Hyperlipidemia due to hepatic triglyceride lipase deficiency
• Hyperlipidemia, combined, 2
• Hyperlipidemia, familial combined, LPL related
• Hyperlipoproteinemia type 3
• Hyperlipoproteinemia type V
• Hyperlipoproteinemia, type 1D
• Laminopathy type Decaudain-Vigouroux

Trials (1,898)

• "Phospholipovit" vs Placebo in Patients With Combined Hyperlipidemia
• "Smart Family Doctor" Assisted Comprehensive Management of Secondary Prevention Among Post Coronary Artery Bypass Graft Patients or Post Percutaneous Coronary Intervention Patients
• "Smart Family Doctor" Assisted Comprehensive Management of Secondary Prevention Among Post Revascularization Patients
• (H.E.L.P.)Apheresis Therapy to Compare the Reduction of LDL (Low Density Lipoprotein) Cholesterol
• [E]PANOVA Combined With a [S]TATIN in [P]ATIENTS With HYPERT[R]IGLYCER[I]DEMIA to Reduce Non-HDL CHOLES[T]EROL
• 12-week Open-label, Phase IIIb Comparing Efficacy and Safety of Rosuvastatin (CRESTOR™) in Combination With Ezetimibe
• 2-HOBA Supplementation in People With Elevated Lipoprotein(a)
• A 10-12 Week Study to Evaluate the Safety and Efficacy of 320 mg Valsartan and 80 mg Simvastatin in Combination and as Monotherapies in Treating Hypertension and Hypercholesterolemia
• A 12 Week Study of MK0653A in Patients Who Have Been Hospitalized for a Possible Heart Problem (0653A-808)
• A 12 Week, 3-Period Study to Evaluate the Effects of a Dietary Supplement on Lipid Metabolism
• A 12-week Post-marketing, Observational Study to Confirm the Safety and Efficacy of Zetia Alone or in Combination With Other Lipid-lowering Drugs in Japanese Subjects With Hypercholesterolemia (Study P05244)
• A 12-Week, Phase 2 Study of Gemcabene in Hypercholesterolemia Patients on Stable Moderate and High-Intensity Statins
• A 16 Week Comparative Study of Fenofibrate Versus Ezetimibe as Add-on Therapy to Atorvastatin
• A 2-Part, Phase 1, Single and Multiple Ascending Dose Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of CAT-2054 in Healthy Subjects
• A 4-week, Randomized, Placebo-Controlled, Double-Blind, Efficacy and Safety Study of HS-25 in Adults With Primary Hypercholesterolemia
• A 52-week Post-marketing, Observational Study to Confirm the Safety and Efficacy of Zetia Alone or in Combination With Other Lipid-lowering Drugs in Japanese Subjects With Hypercholesterolemia (Study P05245)
• A 6-Month Consumer Behavior Study of a Self-Management System (0803-084)(COMPLETED)
• A Brief Intervention to Improve Medication Knowledge and Adherence Among Family Medicine Patients in South Texas
• A CCTA Imaging Trial to Evaluate the Effect of Obicetrapib/Ezetimibe on Coronary Plaque
• A Change in Diet May Decrease the Negative Consequences of Chronic Sleep Deprivation

Approved drugs (14)

• Amlodipine besylate
• Atorvastatin calcium
• Ezetimibe
• Icosapent ethyl
• Niacin
• Pemafibrate
• Pitavastatin calcium
• Pitavastatin magnesium
• Pitavastatin sodium
• Rosuvastatin calcium
• Semaglutide
• Simvastatin
• Sitagliptin phosphate
• Tirzepatide

Drugs in development (65)

• Alirocumab Phase 1
• Amlodipine Phase 1
• Amlodipine maleate Phase 3
• Anacetrapib Phase 2
• Antroquinonol Phase 2
• Atazanavir Phase 3
• Atorvastatin Phase 3
• Bempedoic acid Phase 3
• Berberine Phase 2
• Berberine sulfate Phase 2
• Bococizumab Phase 3
• Cholecalciferol Phase 1
• COENZYME_A Phase 3
• Dalcetrapib Phase 2
• Dextrose Phase 2
• Enlicitide Phase 3
• Enlicitide chloride Phase 3
• Epigalocatechin gallate Phase 2
• Evacetrapib Phase 3
• Evolocumab Phase 3

Other linked drugs (10)

• Acipimox
• Calcium polycarbophil
• Colesevelam hydrochloride
• Exenatide
• Lactobacillus acidophilus
• Metformin
• Omega-3-acid ethyl esters
• Pioglitazone
• Policosanol
• Withanolide D